Search | BIO

Home

Search

237 Results Found

What Biotech Can Expect From the Biden Administration's Agricultural Policy Agenda

With Katherine Tai confirmed unanimously by the Senate as the U.S. Trade Representative (USTR) and Secretary of Agriculture Tom Vilsack in place at the U.S. Department of Agriculture (USDA), the world is now getting a better picture of what U.S. agricultural policy – and the role of biotechnology…

Ozone Action Week Shines Light on How to Truly Address Climate Change

As the country tries to loosen COVID’s grip on society, efforts are focused on reestablishing economic viability while protecting public health. Quite a tall order considering the effects of climate change have been threatening public health long before the coronavirus outbreak, and will only…

One-On-One with Dr. George Scangos on COVID-19 and why the novel coronavirus is such a threat

Biotechnology companies, large and small, are working hard to more effectively treat and safely prevent the spread of COVID-19. For an episode of the I AM BIO Podcast, BIO President & CEO Jim Greenwood was joined by Dr. George Scangos, CEO of Vir and head of BIO’s Coronavirus Collaboration…

Short Sunsets for Priority Review Voucher Programs May Mitigate the Incentive

On January 31, 2020 the Government Accountability Office (GAO) released a report on FDA’s Priority Review Voucher Programs (PRVs), covering the Neglected Tropical Disease (NTD PRV), Rare Pediatric (RPD PRV), and Medical Counter Measures (MCM PRV) Priority Review Voucher programs. The voucher…

One-On-One with Alnylam’s Dr. John Maraganore on RNAi & how it could help address COVID-19

Months into the Coronavirus pandemic, scientists and researchers around the globe are still hunting for treatments and vaccines for the COVID-19 virus. In a recent episode of the I AM BIO podcast, BIO President and CEO Jim Greenwood spoke with Dr. John Maraganore, CEO of Alnylam Pharmaceuticals,…

Q&A: Dr. Mary-Ann Etiebet, Executive Director, Merck for Mothers

With Mother's Day just around the corner, BIO sat down with Dr. Mary-Ann Etiebet, Executive Director of Merck for Mothers, for a discussion about how Merck helping address maternal health needs in the United States and in countries impacted by COVID-19. BIO: What is Merck for…

One-On-One with Dr. Jeremy Levin on biotech’s “finest hour”

With America’s scientists and researchers working around the clock to eradicate COVID-19, BIO President and CEO Jim Greenwood checked in with Dr. Jeremy Levin. Dr. Levin is CEO of Ovid Therapeutics and Chairman of BIO’s board of directors. In a recent edition of the I AM BIO podcast, Dr. Levin…

One-On-One with Moderna CEO Stéphane Bancel on the search for a COVID-19 vaccine (I AM BIO Podcast 3/30)

As countless people, companies, and organizations work together to combat the COVID-19 pandemic, one company is working to eradicate the virus itself at record speed. BIO CEO Jim Greenwood recently spoke with Stéphane Bancel, CEO of Moderna, which is racing to develop a vaccine to stop this deadly…

One-On-One with Dr. George Yancopoulos on Regeneron’s innovative work to treat COVID-19

Many companies in the biotechnology industry are working to find new ways to combat the COVID-19 pandemic. On a recent I AM BIO podcast, BIO CEO Jim Greenwood sat down with Dr. George Yancopoulos, Regeneron’s President, Co-Founder, and Chief Scientific Officer, about how his team is responding and…

One-On-One with Merck's Dr. Julie Gerberding on combatting COVID-19

The biotech industry is working tirelessly to identify new advancements to diagnose, treat, and prevent COVID-19 and help save lives around the world. For a recent I AM BIO podcast, BIO CEO Jim Greenwood sat down with Dr. Julie Gerberding, Executive Vice President at Merck and former head of the…